Legend Biotech Corp Rightofuse Assets
Legend Biotech Corp (LEGN) had Rightofuse Assets of $285.20 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:RightofuseAssets · last filed 2026-03-10
- 2025-12-31: Rightofuse Assets $285.20M.
- 2025-09-30: Rightofuse Assets $142.34M.
- 2025-06-30: Rightofuse Assets $127.22M.
- 2025-03-31: Rightofuse Assets $107.22M.
| Period end | Rightofuse Assets | Rightofuse Assets as first filed |
|---|---|---|
| 2025-12-31 | $285.20M 20-F · filed 2026-03-10 | |
| 2025-09-30 | $142.34M 6-K · filed 2025-11-12 | |
| 2025-06-30 | $127.22M 6-K · filed 2025-08-11 | |
| 2025-03-31 | $107.22M 6-K · filed 2025-05-13 | |
| 2024-12-31 | $101.90M 20-F · filed 2026-03-10 | $101.93M 20-F · filed 2025-03-11 |
| 2024-09-30 | $99.45M 6-K · filed 2024-11-12 | |
| 2024-06-30 | $114.72M 6-K · filed 2024-08-09 | |
| 2024-03-31 | $80.18M 6-K · filed 2024-05-13 | |
| 2023-12-31 | $80.40M 20-F · filed 2026-03-10 | $80.50M 20-F · filed 2024-03-19 |
| 2023-09-30 | $74.81M 6-K · filed 2023-11-20 | |
| 2023-06-30 | $78.50M 6-K · filed 2023-08-15 | |
| 2022-12-31 | $55.59M 20-F · filed 2025-03-11 | |
| 2021-12-31 | $38.28M 20-F · filed 2024-03-19 | $7.19M 20-F · filed 2022-03-31 |
| 2021-06-30 | $7.31M 6-K · filed 2021-08-23 | |
| 2020-12-31 | $39.54M 20-F · filed 2023-03-30 | $8.01M 20-F · filed 2021-04-02 |
| 2020-01-01 | $27.79M 20-F/A · filed 2023-02-17 | |
| 2019-12-31 | $27.79M 20-F/A · filed 2023-02-17 | $9.35M 20-F · filed 2021-04-02 |
| 2018-12-31 | $3.73M 20-F · filed 2021-04-02 |